Number of Shares
149,175.00
Current Holdings Value*
$9.52 Mil
% of Portfolio
2.49%
Total Estimate Gain
$1.76 Mil
% of Total Estimate Gain
10.86%

HARVEY CAPITAL MANAGEMENT INC's Halozyme Therapeutics Inc Holding Summary

As of 2025-03-31, HARVEY CAPITAL MANAGEMENT INC held 149,175.00 shares of Halozyme Therapeutics Inc(HALO), totaling $9.52 Mil. This investment constitutes 2.49% of their stock portfolio, and HARVEY CAPITAL MANAGEMENT INC now holds 0.12% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2014Q1. And since then HARVEY CAPITAL MANAGEMENT INC has made 5 purchases of HALO, at an average price of $17.45, for a total of 926,640.00 shares. In addition, there have been 8 sales at an average price of $11.81 for 777,465.00 shares. Based on historical transaction data and HALO's current price of $58.59, HARVEY CAPITAL MANAGEMENT INC's estimated gain on his HALO holdings is $1.76 Mil, reflecting a 10.86% gain to date.

HARVEY CAPITAL MANAGEMENT INC HALO ($58.59) Holding Chart

HARVEY CAPITAL MANAGEMENT INC HALO ($58.59) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1